1. Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial. Issue 1 (31st December 2022) Authors: Muranushi, Hiroyuki; Kanda, Junya; Kobayashi, Masayuki; Maeda, Takeshi; Kitano, Toshiyuki; Tsuji, Masaaki; Ueda, Yasunori; Ishikawa, Takayuki; Nohgawa, Masaharu; Watanabe, Mitsumasa; Imada, Kazunori; Moriguchi, Toshinori; Itoh, Mitsuru; Ohno, Hitoshi; Yonezawa, Akihito; Hirata, Hirokazu; Arima, N... Journal: Hematology Issue: Volume 27:Issue 1(2022) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗